Ivacaftor Reduces Inflammatory Mediators in Upper Airway Lining Fluid From Cystic Fibrosis Patients With a G551D Mutation: Serial Non-Invasive Home-Based Collection of Upper Airway Lining Fluid

In cystic fibrosis (CF) therapy, the recent approval of CF-transmembrane conductance regulator (CFTR) channel modulators is considered to be the major breakthrough. However, the current first-line approach based mainly on pulmonary function to measure effects of the novel therapy, tested by forced e...

Descripción completa

Detalles Bibliográficos
Autores principales: Mainz, Jochen G., Arnold, Christin, Wittstock, Kara, Hipler, Uta-Christina, Lehmann, Thomas, Zagoya, Carlos, Duckstein, Franziska, Ellemunter, Helmut, Hentschel, Julia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8131546/
https://www.ncbi.nlm.nih.gov/pubmed/34025651
http://dx.doi.org/10.3389/fimmu.2021.642180

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8131546/
https://www.ncbi.nlm.nih.gov/pubmed/34025651
http://dx.doi.org/10.3389/fimmu.2021.642180

Ejemplares similares